Chida et al. study showed that the IFNγ pathway was upregulated in patients who responded to ICI treatment, consistent with previous studies that linked an IFNγ-related mRNA profile to better outcomes with ICIs across various cancers. This evidence concerns the gene IFNG and cancer.